![Michael Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bailey
Algemeen Directeur bij
AVEO PHARMACEUTICALS, INC.
Vermogen: 467 640 $ op 31-05-2026
Profiel
Michael P.
Bailey is currently President, Chief Executive Officer & Director at AVEO Pharmaceuticals, Inc. since 2010.
He is Chairman at IMV, Inc. since 2022 and Director at Verastem, Inc. starting in 2026.
Formerly, Mr. Bailey was a Member of Global Commercial Partnership Teams at Genentech, Inc., Senior Vice President-Commercial Operations at ImClone LLC from 1999 to 2008, and Chief Commercial Officer & Senior Vice President at Synta Pharmaceuticals Corp.
from 2008 to 2010.
Education includes undergraduate studies at St. Lawrence University and an MBA from Mendoza College of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERASTEM, INC. 0,18% | 21-05-2026 | 108.000 ( 0,18% ) | 467 640 $ | 31-05-2026 |
Actieve functies van Michael Bailey
| Bedrijven | Functie | Begin |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Algemeen Directeur | 06-01-2015 |
| IMV INC. | Voorzitter | 01-05-2022 |
| VERASTEM, INC. | Directeur/Bestuurslid | 26-05-2026 |
Eerdere bekende functies van Michael Bailey
| Bedrijven | Functie | Einde |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Corporate Officer/Principal | 07-09-2010 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01-08-2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Opleiding van Michael Bailey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Mendoza College of Business
 Mendoza College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
